News

Discover how researchers are using NIH/NCI genomics and proteomics data to gain insight into chemotherapy resistance in triple negative breast cancer.

An extensive data collection on Juvenile Myelomonocytic Leukemia is now available. The data were made available thanks to funding from the Cancer Childhood Data Initiative, offering researchers greater insight into the genetic, epigenetic, and biochemical basis of this Ras-driven leukemia.

Genomic studies of childhood and rare cancers got a major boost, as a new optimized workflow for managing these data was recently reported in Nature Communications. And, thanks to funding by NCI’s Childhood Cancer Data Initiative, it’s easier and faster to share those data with the cancer research community.

The Frederick National Laboratory for Cancer Research’s Laboratory of Human Retrovirology and Immunoinformatics has updated its bioinformatics resource system known as DAVID. The system provides investigators with a set of functional annotation tools to better understand the biological meaning behind large lists of genes.

CBIIT Director, Dr. Tony Kerlavage, sat down recently for a podcast examining the evolution of NCI’s Data Commons. He tracked the development of the Cancer Research Data Commons, from its early pilots to today’s cloud-based infrastructure, with repositories of diverse data and more than 1,000 tools and resources.

In the latest episode of the Center for Cancer Genomics (CCG) podcast, “Personal Genomics,” CCG honors the work and legacy of Dr. Daniela S. Gerhard. Dr. Gerhard was a program director and passionate open data advocate who spent nearly two decades developing large-scale genomics and translational research programs at NCI.

NIH needs input on potential updates to the NIH Genomic Data Sharing Policy! As a researcher or data scientist, share your perspective related to cancer genomic data to help the policy keep pace with evolving scientific opportunities and stakeholder expectations. Responses to the Request for Information will be accepted through February 28, 2022.

NCI DATA Scholar Dr. Jay G. Ronquillo recently published a study using NIH “All of Us” data and NCI’s Cancer Research Data Commons to better understand pharmacogenomic prescribing and testing patterns across the United States.

The NCI Cancer Research Data Commons has recently added 1,000 new clinical outcome data files for Clinical Proteomic Tumor Atlas Consortium (CPTAC) studies to NCI’s Genomic Data Commons and Proteomic Data Commons.

In a recent podcast, NCI leaders from CBIIT and the Small Business Innovation Research Development Center shared how technological developments have enhanced cancer research and have helped usher in new diagnostics, treatments, and patient care.